Healthcare Sales & Marketing Network News: weight loss

Searching News Database: weight loss

HSMN NewsFeed - 11 Jun 2026
Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Dec 2025
U.S. FDA Approves JASCAYD(R) (nerandomilast) Tablets for the Treatment of Progressive Pulmonary Fibrosis in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Oct 2025
Lumen Bioscience Expands Board and Leadership Team to Advance Clinical Pipeline of Novel Oral Biologics
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jun 2025
Viking Therapeutics Announces Initiation of Phase 3 Obesity Clinical Program with GLP-1/GIP Agonist VK2735
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 18 Sep 2024
Accord BioPharma, Inc. Announces U.S. Food & Drug Administration Approval of 420mg Strength of HERCESSI(TM) (trastuzumab-strf), a biosimilar to Herceptin(R) (trastuzumab), for the Treatment of Several Forms of HER2-Overexpressing Cancer
Biopharmaceuticals Generics Oncology FDA

HSMN NewsFeed - 14 Jun 2024
TALVEY(R) (talquetamab-tgvs) Demonstrates Highly Durable, Longer-Term Responses in Patients with Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Feb 2024
Spatz Medical Marks Milestone: Spatz3 Adjustable Gastric Balloon Launches in the U.S. in March 2024
Devices Gastroenterology Product Launch

HSMN NewsFeed - 6 Nov 2023
NeuroBo Pharmaceuticals Strengthens Board of Directors with the Appointment of James P. Tursi, M.D.
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Oct 2023
FDA Approves Novartis Cosentyx(R) as the First New Biologic Treatment Option for Hidradenitis Suppurativa Patients in Nearly a Decade
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Jun 2023
Astellas Submits New Drug Application for Zolbetuximab in Japan
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 12 May 2023
NeuroBo Pharmaceuticals, Inc. Appoints Pharmaceutical Industry Executive, Mark A. Glickman, to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Jan 2023
NeuroBo Pharmaceuticals Appoints Joseph Hooker as Interim Chief Executive Officer and President
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Nov 2022
Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
Devices Surgery Mergers & Acquisitions

HSMN NewsFeed - 26 Oct 2022
New Reimbursement Approved by the Japanese Ministry of Health, Labor and Welfare for the Accuray CyberKnife(R) System to Treat Trigeminal Neuralgia, a Condition Often Causing Severe Facial Pain
Devices Reimbursement

HSMN NewsFeed - 22 Sep 2022
Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment of Obesity and Cardio-Metabolic Disorders
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 21 Jul 2022
Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO(R) (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 27 Apr 2022
New Studies Demonstrate Clinical Benefits of Patient-and Provider-Supportive Technology in Diabetes Management
Devices Monitoring Endocrinology

HSMN NewsFeed - 6 Apr 2022
FDA approves Novartis Vijoice(R) (alpelisib) as first and only treatment for select patients with PIK3CA-Related Overgrowth Spectrum (PROS)
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Feb 2022
After Successful Launch of Titan SGS(R) Surgical Stapler, Standard Bariatrics, Inc. Achieves Final Series B Funding Early
Devices Surgery Venture Capital

HSMN NewsFeed - 31 Jan 2022
Spatz3 Adjustable Balloon Delivers the Highest Weight Loss Results
Devices Gastroenterology

HSMN NewsFeed - 19 Jan 2022
Titan SGS(R) from Standard Bariatrics, Inc. Passes 1,000 Clinical Case Uses
Devices Surgery

HSMN NewsFeed - 13 Dec 2021
Standard Bariatrics, Inc. Reaches Sales Milestone with Titan SGS(TM)
Devices Surgery

HSMN NewsFeed - 9 Aug 2021
SKYRIZI(R) (risankizumab-rzaa) Now Available in the U.S. as a Single 150 mg Injection for Adults with Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology Product Launch

HSMN NewsFeed - 5 Aug 2021
Aardvark Therapeutics, Inc., Completes $29m Series B Funding Led By Sorrento Therapeutics And Including Existing Investors And The Foundation For Prader-Willi Research
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 21 Jul 2021
Corium Launches Innovative ADHD Treatment AZSTARYS(TM) (serdexmethylphenidate and dexmethylphenidate) in the U.S. for Patients Age 6 Years and Older
Biopharmaceutical Neurology Product Launch

HSMN NewsFeed - 30 Jun 2021
Mitsubishi Tanabe Pharma America Announces EXSERVAN(TM) (riluzole) is Now Available in the U.S. for the Treatment of ALS
Biopharmaceuticals Neurology Product Launch

HSMN NewsFeed - 12 Feb 2021
The Lancet Publishes Libtayo(R) (cemiplimab) Data Showing Extended Overall Survival in Patients with First-line Advanced Non-small Cell Lung Cancer with PD-L1 Expression of ≥50%
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Feb 2021
BrainCool AB (publ) Receives FDA "Breakthrough Device" Designation for Cooral(R) System for Prevention of Oral Mucositis
Devices FDA

HSMN NewsFeed - 16 Oct 2020
Akero Therapeutics Receives European Medicines Agency Priority Medicines (PRIME) Designation for Efruxifermin (EFX) in NASH
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Sep 2020
BrainCool Announces Statistically Significant Late-Breaking Clinical Data at ESMO Virtual Congress 2020
Devices Oncology

HSMN NewsFeed - 24 Jul 2020
Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infections Caused by MAC in Non-CF Patients with Limited Treatment Options
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 14 Jul 2020
TREMFYA(R) (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Jun 2020
Janssen Announces Discontinuation of Phase 3 LOTUS Study Evaluating Ustekinumab in Systemic Lupus Erythematosus
Biopharmaceuticals

HSMN NewsFeed - 25 Mar 2020
Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Jan 2020
PANTHERx(R) Rare Pharmacy Selected by Blueprint Medicines Corporation to Distribute AYVAKIT(TM) (avapritinib) for Genomically Defined Patient Population with Rare Cancer, GIST
Biopharmaceuticals Oncology Distribution

HSMN NewsFeed - 13 Dec 2019
Clinical Data from Reprieve Cardiovascular's Successful First-in-Human Therapy for Acute Heart Failure Presented
Devices Cardiology

HSMN NewsFeed - 5 Nov 2019
Regeneron Provides Updates on Phase 3 Libtayo(R) (cemiplimab) Development Program in Advanced Non-small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Oct 2019
FDA Grants Ofev(R) Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Oct 2019
Upsher-Smith Laboratories Launches Tosymra(TM) (sumatriptan) Nasal Spray For The Acute Treatment Of Migraine In Adults
Biopharmaceuticals Neurology Drug Delivery Product Launch

HSMN NewsFeed - 27 Sep 2019
Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Aug 2019
Amgen To Acquire Otezla(R) For $13.4 Billion In Cash, Or Approximately $11.2 Billion Net Of Anticipated Future Cash Tax Benefits
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 14 Jun 2019
Janssen reports top-line Phase 3 results for TREMFYA(R) (guselkumab) in adults with active psoriatic arthritis
Biopharmaceuticals

HSMN NewsFeed - 26 Apr 2019
Aratana Therapeutics to be Acquired by Elanco Animal Health
Biopharmaceuticals Veterinary Mergers & Acquisitions

HSMN NewsFeed - 18 Mar 2019
Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD
Biopharmaceuticals FDA Regulatory

HSMN NewsFeed - 17 Jul 2018
BAROnova Announces Submission of Premarket Approval (PMA) Application to the U.S. FDA for the TransPyloric Shuttle(R) (TPS(R)) Device Intended for the Treatment of Obesity
Devices FDA

HSMN NewsFeed - 2 Jul 2018
Phase III IMpassion130 Study Showed Genentech's TECENTRIQ Plus Abraxane Significantly Reduced the Risk of Disease Worsening or Death in People With Metastatic or Locally Advanced Triple Negative Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Jun 2018
Artelo Biosciences Enters Into Global R&D Partnership With Syngene International And Aptus Clinical For The Clinical Development Of ART27.13 In Oncology
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 May 2018
ReShape Lifesciences Announces Submission for Approval of ReShape Balloon(TM) in Canada
Devices Regulatory

HSMN NewsFeed - 16 Apr 2018
Apitope Announces Positive Results with Novel Treatment for Graves' Disease
Biopharmaceuticals

HSMN NewsFeed - 26 Feb 2018
New Data Show Lilly's Trulicity(R) (dulaglutide) in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 22 Jan 2018
Elanco Animal Health Announces U.S. Food and Drug Administration (FDA) Approval of Credelio(R) (lotilaner) to Treat and Protect Against Ticks and Fleas
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jan 2018
Novartis new data reinforces superiority of Cosentyx(R) versus Stelara(R) in achieving skin clearance for psoriasis patients
Biopharmaceuticals Dermatology

HSMN NewsFeed - 10 Jan 2018
BYDUREON(R) BCise(TM) Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
Biopharmaceuticals Endocrinology Product Launch

HSMN NewsFeed - 1 Dec 2017
FDA approves first biosimilar for the treatment of certain breast and stomach cancers
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 20 Oct 2017
Celgene Provides Update on GED-0301 (mongersen) Inflammatory Bowel Disease Program
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 12 Oct 2017
Ortho Dermatologics Announces Two-Year Findings From Pivotal Phase 3 Study Of SILIQ(TM) (brodalumab) Injection Data Demonstrating Long-Term Efficacy Profile
Biopharmaceuticals Dermatology

HSMN NewsFeed - 3 Oct 2017
EnteroMedics Announces Acquisition Of ReShape Medical
Devices Mergers & Acquisitions

HSMN NewsFeed - 14 Sep 2017
Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Aug 2017
Orexigen Therapeutics Announces Commercialization and Distributorship Arrangement with Cheplapharm Arzneimittel GmbH for Mysimba(TM) in Germany, France and Austria
Biopharmaceuticals Distribution

HSMN NewsFeed - 28 Jul 2017
Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR(R) NECTAR (barium sulfate) Oral Suspension
Diagnostics Radiology Gastroenterology FDA

HSMN NewsFeed - 25 Jul 2017
EnteroMedics Announces First Veterans Choice Program vBloc(R) Implant for Obesity at Methodist Dallas Medical Center
Devices

HSMN NewsFeed - 21 Jun 2017
EnteroMedics Announces vBloc Therapy to be Presented by Keynote Speaker at Major International Obesity Conference
Devices

HSMN NewsFeed - 31 May 2017
EnteroMedics Announces First vBloc(R) Neurometabolic Therapy Implant at AMITA Health Adventist Medical Center Bolingbrook
Devices Neurology

HSMN NewsFeed - 18 May 2017
EnteroMedics Announces First vBloc(R) Neurometabolic Therapy Implant at McGuire Veterans Affairs Medical Center
Devices Neurology

HSMN NewsFeed - 11 May 2017
Rhythm Receives Expanded FDA Breakthrough Therapy Designation for Setmelanotide for Rare Genetic Disorders of Obesity
Biopharmaceuticals FDA

HSMN NewsFeed - 2 May 2017
Orexigen Therapeutics Announces Commercialization and Distributorship Arrangement with Navamedic ASA for Mysimba(R) (naltrexone HCl / bupropion HCl prolonged release) in Five Nordic Countries
Biopharmaceuticals Distribution

HSMN NewsFeed - 28 Apr 2017
Novartis Receives FDA Approval for Rydapt(R) in Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML) and Three Types of Systemic Mastocytosis (SM)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 24 Apr 2017
SIR-Spheres(R) Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows
Devices Oncology

HSMN NewsFeed - 19 Apr 2017
USGI Medical Appoints Carlos Babini as President and Chief Executive Officer
Devices Gastroenterology Personnel

HSMN NewsFeed - 5 Jan 2017
Eisai Acquires All Global Development And Marketing Rights For Chronic Weight Management Treatment Lorcaserin HCI
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 16 Dec 2016
Janssen Submits Application Seeking FDA Approval of STELARA(R) (Ustekinumab) for the Treatment of Adolescents with Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 14 Dec 2016
Health Canada approves STELARA(R) for the treatment of adults with moderately to severely active Crohn's disease
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 8 Nov 2016
Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Valeant for Contrave(R) (naltrexone HCl / bupropion HCl extended release) in Australia and New Zealand
Biopharmaceuticals Distribution

HSMN NewsFeed - 4 Nov 2016
ReShape Medical, Inc. Unveils US Commercial Data Demonstrating Increased Weight Loss with ReShape(R) Dual Balloon
Devices Gastroenterology

HSMN NewsFeed - 24 Oct 2016
Efficacy of Ofev(R) (nintedanib) Reinforced in Range of Patients with IPF in New Analyses Presented at CHEST
Biopharmaceuticals

HSMN NewsFeed - 18 Oct 2016
Shire Granted EU Marketing Authorization of Onivyde(R), in Combination With 5-Fluorouracil (5-FU) and Leucovorin (LV),for the Treatment of Metastatic Adenocarcinoma of the Pancreas in Adult Patients Who Have Progressed Following Gemcitabine-Based Therapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 17 Oct 2016
Teva Receives Positive Opinion from European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to Extend Indication of Trisenox(R) for First Line Treatment of Low- to Intermediate Risk Acute Promyelocytic Leukemia (APL)
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 20 Sep 2016
KVK Tech Announces FDA-Approval of Lomaira(TM) (phentermine hydrochloride USP) 8 mg tablets, CIV, A Low-Cost, Low-Dose Phentermine That Can Be Used Up To Three Times Daily for Weight Reduction
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Sep 2016
vBloc Institute Demonstrates Positive Clinical Success in Patients Struggling with Weight Loss as Compared to Pivotal FDA Trial with EnteroMedics vBloc(R) Therapy in Combination with vBloc(R) Achieve Program
Devices Neurology

HSMN NewsFeed - 12 Sep 2016
Obalon Announces FDA Approval of Obalon Balloon System
Devices Gastroenterology FDA

HSMN NewsFeed - 8 Aug 2016
ReShape Medical(R) Announces the Appointment of Michael J. Mangano as President and Chief Executive Officer
Devices Gastroenterology Personnel

HSMN NewsFeed - 1 Aug 2016
Orexigen Completes Acquisition of All U.S. Rights to Contrave(R) and Launches U.S. Sales Organization
Biopharmaceuticals Acquisitions Product Launch

HSMN NewsFeed - 22 Jul 2016
VIVUS Announces Favorable Markman Ruling in Qsymia(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 5 Jul 2016
Insys Therapeutics Announces FDA Approval of Syndros(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Jun 2016
OPKO Health to Acquire Transition Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 29 Jun 2016
EnteroMedics Highlights Recent Patient Success with vBloc(R) Therapy in Combination with vBloc(R) Achieve Program
Devices

HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 1 Jun 2016
EnteroMedics Announces First-of-its-Kind Procedure with vBloc(R) Therapy Used as Adjunctive Rescue Treatment for Failed Gastric Sleeve in Patients with Obesity
Devices

HSMN NewsFeed - 16 May 2016
Neos Therapeutics Announces U.S. Launch of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients Six Years and Older
Biopharmaceuticals Product Launch

HSMN NewsFeed - 2 May 2016
EnteroMedics Announces Exclusive Federal Government Business Channel Sales Agreement with Academy Medical to Provide vBloc(R) Neurometabolic Therapy to US Department of Veterans Affairs Medical Facilities
Devices Distribution

HSMN NewsFeed - 27 Apr 2016
Novartis Receives Three FDA Breakthrough Therapy Designations for IlaristTo Treat Rare Types of Periodic Fever Syndromes
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Apr 2016
AbbVie Receives CHMP Positive Opinion for HUMIRA(R) (adalimumab) for the Treatment of Pediatric Patients, from Six Years of Age, with Moderately to Severely Active Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 18 Mar 2016
STELARA(R) Induced Clinical Response And Remission In Phase 3 Study For The Treatment Of Patients With Moderate To Severe Crohn's Disease Who Had Previously Failed Or Were Intolerant To Anti-TNF-Alpha Therapy
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 15 Mar 2016
Orexigen and Takeda Jointly Announce Orexigen's Acquisition of All Rights to CONTRAVE(R) in the United States
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 17 Feb 2016
Impax Receives FDA Approval for Generic Version of Adderall XR(R) (mixed salts of a single-entity amphetamine product) Capsules, CII
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 16 Feb 2016
Helsinn Group Signs Exclusive Agreement With Mundipharma for the Distribution and Licence of Anamorelin in Northern Europe Countries
Biopharmaceuticals Oncology Licensing Distribution

HSMN NewsFeed - 1 Feb 2016
Aoxing Pharma Appoints Dr. James Chen as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jan 2016
Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients 6 Years and Older
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 27 Jan 2016
MetaCure Announces Appointment of New CEO
Devices Endocrinology Personnel

HSMN NewsFeed - 18 Dec 2015
Gelesis Closes $31.5 Million Growth Financing
Biopharmaceuticals Endocrinology Venture Capital

HSMN NewsFeed - 22 Oct 2015
Merrimack Announces U.S. FDA Approval of ONIVYDE(TM) (irinotecan liposome injection) for the Treatment of Patients with Metastatic Pancreatic Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 3 Sep 2015
Helsinn Group Signs Exclusive Agreement With Mundipharma for the Distribution and Licence of anamorelin in Switzerland and Liechtenstein
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 11 Aug 2015
FDA Approves Orbera(TM) Bariatric System
Devices Gastroenterology Surgery FDA

HSMN NewsFeed - 24 Jul 2015
FDA approves Novartis drug Odomzo(R) (sonidegib) for locally advanced basal cell carcinoma (laBCC), a form of skin cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 20 May 2015
EnteroMedics Announces First US Commercial Implant of vBloc(R) Neurometabolic Therapy System at Tufts Medical Center in Boston, Massachusetts
Devices

HSMN NewsFeed - 18 May 2015
Apollo Endosurgery, Inc. Announces the Presentation of ORBERA(TM) Intragastric Balloon US Pivotal Trial Results at Digestive Disease Week(R) 2015 Conference (DDW)
Devices Gastroenterology

HSMN NewsFeed - 23 Dec 2014
Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer
Devices Monitoring Personnel

HSMN NewsFeed - 16 Dec 2014
Novartis gains FDA approval for Signifor(R) LAR to treat patients with acromegaly, a rare and life-threatening hormonal disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Jul 2014
Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR(R) (sorafenib) in Patients with Advanced Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Jul 2014
Nexavar(R) (sorafenib tablets) now Approved in Canada for the Treatment of Differentiated Thyroid Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 6 May 2014
FDA Approves EPANOVA for the Treatment of Adults with Severe Hypertriglyceridemia
Biopharmaceuticals FDA

HSMN NewsFeed - 1 May 2014
FDA Approves Inspire(R) Upper Airway Stimulation (UAS) Therapy for Obstructive Sleep Apnea
Devices FDA

HSMN NewsFeed - 9 Apr 2014
EnteroMedics Inc. Appoints Mark Bullivant as Vice President of Marketing
Devices Personnel

HSMN NewsFeed - 11 Mar 2014
Bayer and Onyx Report Phase 3 Study Results of NEXAVAR(R) (sorafenib) as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Mar 2014
Incyte Announces Positive Top-Line Results from Phase III Study of Ruxolitinib in Patients with Polycythemia Vera
Biopharmaceuticals

HSMN NewsFeed - 3 Mar 2014
U.S. FDA Approves Bydureon(R) Pen (exenatide extended-release for injectable suspension) for Once-Weekly Treatment of Adults with Type 2 Diabetes
Biopharmaceuticals Drug Delivery Endocrinology FDA

HSMN NewsFeed - 20 Feb 2014
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Colorectal Cancer after Resection of Liver Metastases
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 Dec 2013
Takeda Announces Exclusive License and Option Agreement with Natrogen for Development of Natura-alpha for Inflammatory Bowel Disease
Biopharmaceuticals Gastroenterology Licensing

HSMN NewsFeed - 9 Dec 2013
FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 14 Nov 2013
Jeffrey Paley, MD, Joins Retrophin Inc.’s Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Oct 2013
Cimzia(R) (Certolizumab Pegol) Approved by FDA for Treatment of Adults with Active Ankylosing Spondylitis
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Oct 2013
Given Imaging Announces Data Confirming PillCam(R) SB Can Improve Management and Outcomes in Patients With Crohn's Disease
Devices Gastroenterology

HSMN NewsFeed - 9 Oct 2013
USGI Medical Receives FDA Approval to Launch Head-to-Head Pivotal Study to Determine Safety, Effectiveness of Incisionless, Endoscopic Weight Loss Procedure
Devices Surgery FDA

HSMN NewsFeed - 30 Sep 2013
Cimzia(R) (certolizumab pegol) approved by the U.S. FDA for treatment of adult patients with active psoriatic arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Sep 2013
EnteroMedics on Track for Approval Decision in First Half of 2014 Following Formal Response to Premarket Approval Application From FDA
Devices FDA

HSMN NewsFeed - 30 Aug 2013
Bayer's Stivarga(R) (regorafenib) Tablets Approved in Europe
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 23 Aug 2013
ChemoCentryx Announces GlaxoSmithKline's Release of Top-Line Results From the SHIELD-1 Phase III Study of Vercirnon
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 7 Jun 2013
Eisai Announces Availability of BELVIQ(R) (lorcaserin HCl) CIV Tablets for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese
Biopharmaceuticals

HSMN NewsFeed - 15 May 2013
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Advanced Liver Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 May 2013
Curis Announces Approval of Erivedge(R) in Australia
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 10 May 2013
Novartis drug Ilaris(R) approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis
Biopharmaceuticals. FDA

HSMN NewsFeed - 1 May 2013
New Guidelines From American Association of Clinical Endocrinologists Recommend Medical Treatment of Obesity
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 26 Apr 2013
Curis Announces Erivedge(R) Receives Positive CHMP Opinion for Conditional Approval in European Union
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 2 Apr 2013
Apollo Endosurgery's OverStitch(TM) Endoscopic Suturing Platform Launches in Europe
Devices Surgery Regulatory Product Launch

HSMN NewsFeed - 6 Mar 2013
GI Dynamics Announces Agreement with CMS Medical for Distribution of EndoBarrier(R) Therapy in Brazil
Devices Distribution

HSMN NewsFeed - 20 Feb 2013
EnteroMedics Names Greg S. Lea Chief Operating Officer
Devices Personnel

HSMN NewsFeed - 14 Feb 2013
Elcelyx Therapeutics Completes $20 Million Series C Financing to Advance NewMet and Lovidia
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 22 Jan 2013
SafeStitch Medical(R) Announces Encouraging Result of Transluminal Procedure to Correct GERD and Obesity with Two Years Follow Up
Devices Gastroenterology

HSMN NewsFeed - 3 Jan 2013
Given Imaging Launches New ManoView(TM) ESO v3.0 Software
Devices Gastroenterology

HSMN NewsFeed - 3 Jan 2013
Phase 3 DECISION Trial of Nexavar(R) (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival in Patients with Radioactive Iodine Refractory Differentiated Thyroid Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Jan 2013
FDA Approves Fulyzaq(TM) (Crofelemer) 125 mg Delayed-Release Tablets for the Symptomatic Relief of Diarrhea in Patients with HIV/AIDS on Anti-Retroviral Therapy (ART)
Biopharmaceuticals FDA HIV/AIDS

HSMN NewsFeed - 21 Dec 2012
FDA Approves Gattex(R) (teduglutide [rDNA Origin]) for Injection for the Treatment of Adult Short Bowel Syndrome
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 4 Dec 2012
Zafgen Secures $21 Million in Series D Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 29 Oct 2012
Bayer's Stivarga(R) (regorafenib) Tablets New Drug Application Granted Priority Review by U.S. FDA for the Treatment of Patients with Gastrointestinal Stromal Tumors
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 27 Sep 2012
Bayer's Stivarga(R) (regorafenib) Tablets Approved by U.S. FDA for Treatment of Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 4 Sep 2012
Revestive(R) (teduglutide) Receives European Marketing Authorization for the Treatment of Adults with Short Bowel Syndrome (SBS)
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 4 Sep 2012
Higher dose of Novartis drug Exelon(R) Patch approved by FDA for patients with mild to moderate Alzheimer's disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 23 Jul 2012
Addition of Tarceva(R) (erlotinib) to Nexavar(R) (sorafenib) did not Provide Additional Benefit to Patients with Unresectable Liver Cancer Versus Nexavar alone in Phase 3 Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Jun 2012
Takeda Receives Positive CHMP Opinion for Teduglutide (Revestive(R)) for Patients with Short Bowel Syndrome
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 19 Jun 2012
Covidien Launches World’s First Knotless Suture Reload for Laparoscopic and Single-Incision Procedures
Devices Surgery

HSMN NewsFeed - 22 May 2012
Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Apr 2012
VIVUS Appoints Ernest Mario, Ph.D. to the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Apr 2012
GI Dynamics Announces First Cases of EndoBarrier(R) Therapy in Australia
Devices Gastroenterology

HSMN NewsFeed - 27 Mar 2012
VIVUS Announced Expansion of Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Mar 2012
BYETTA(R) Approved for Use with Basal Insulin in Europe
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 2 Mar 2012
Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control
Biopharmaceuticals Regulatory

HSMN NewsFeed - 15 Feb 2012
FDA Accepts Pfizer’s New Drug Application for Tafamidis Meglumine, a Novel, Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)
Biopharmaceuticals Neurology

HSMN NewsFeed - 15 Feb 2012
Santarus Announces FDA Acceptance of UCERIS New Drug Application for Induction of Remission of Active Ulcerative Colitis
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 13 Feb 2012
Santarus Announces Initiation of Phase IIIb Study with UCERIS in Patients with Mild or Moderate Active Ulcerative Colitis
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 30 Jan 2012
Curis Announces FDA Approval of Erivedge(TM) (vismodegib) Capsule as First Treatment for Advanced Basal Cell Carcinoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 20 Jan 2012
Remicade(R) (Infliximab) Receives Positive Opinion From CHMP In Europe for Treatment of Ulcerative Colitis in Pediatric Patients
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 23 Dec 2011
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity
Biopharmaceuticals

HSMN NewsFeed - 13 Dec 2011
EnteroMedics Receives First Approval for the Active Implantable Medical Device Components of the Maestro System From Australian Therapeutic Goods Administration (TGA)
Devices Regulatory

HSMN NewsFeed - 17 Nov 2011
Pfizer’s Vyndaqel(R) (tafamidis) First Therapy Approved in the European Union for the Rare and Fatal Neurodegenerative Disease Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 9 Nov 2011
FDA Accepts Genentech’s New Drug Application For Vismodegib in Advanced Form of Skin Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Nov 2011
Lilly and Amylin Mutually Agree to End Diabetes Alliance and Transition Exenatide Responsibility to Amylin
Biopharmaceuticals

HSMN NewsFeed - 7 Nov 2011
IntraPace Introduces New Lead For abiliti(R) System Resulting in Reduced Procedure Time
Devices Regulatory

HSMN NewsFeed - 31 Oct 2011
Given Imaging Announces New Studies Validate Use of PillCam SB(R) to Detect and Monitor Crohn's Disease
Devices Gastroenterology

HSMN NewsFeed - 27 Oct 2011
Lilly Foundation Commits US $30 Million to The Lilly MDR-TB Partnership
Biopharmaceuticals

HSMN NewsFeed - 12 Oct 2011
Onyx Pharmaceuticals and Bayer Healthcare Restructure Global Oncology Partnership
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Sep 2011
Varian Medical Systems to Exhibit Product Enhancements Designed to Make Treatment with Varian Radiotherapy and Radiosurgery Systems Faster, Easier, More Accurate, and Cost Effective
Devices Oncology

HSMN NewsFeed - 13 Sep 2011
Alvine Pharmaceuticals Appoints James D. Watson as Senior Vice President and Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Sep 2011
Genentech Submits New Drug Application to FDA for Vismodegib for Rare Form of Advanced Skin Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Sep 2011
EnteroMedics Announces Presentation of Maestro(R) RC System Clinical Data at the XVI World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders
Devices Surgery

HSMN NewsFeed - 5 Aug 2011
Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 15 Jul 2011
Pertuzumab Combined With Herceptin and Chemotherapy Significantly Extended the Time People With HER2-Positive Metastatic Breast Cancer Lived Without Their Disease Getting Worse
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Jul 2011
Zafgen Secures $33 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 21 Jun 2011
Bydureon Receives Marketing Authorization in Europe
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 21 Jun 2011
TESARO Announces $101 Million Series B Financing for Advancement and Expansion of Oncology Product Portfolio
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 17 May 2011
KCI’s TSS Business Unit Announces First Non-Foam-Based Pressure Redistribution Surface Available in U.S. for Patients up to 1000 Pounds
Devices

HSMN NewsFeed - 16 May 2011
Lilly Provides Its Perspective in Response to Amylin Lawsuit
Biopharmaceuticals Litigation

HSMN NewsFeed - 16 May 2011
Lilly Provides Statement in Response to Amylin Lawsuit
Biopharmaceuticals Litigation

HSMN NewsFeed - 16 May 2011
Amylin Pharmaceuticals Files Suit Against Eli Lilly
Biopharmaceuticals Litigation

HSMN NewsFeed - 15 Apr 2011
BYDUREON Recommended for Approval in Europe
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 4 Apr 2011
Orexigen(R) Therapeutics Presents Additional Contrave(R) Data from Phase 3 COR-II Trial on 24-Hour Ambulatory Blood Pressure Monitoring
Biopharmaceuticals

HSMN NewsFeed - 31 Mar 2011
VICTRELIS(TM) (boceprevir), Merck's Investigational Medicine, Added to Peginterferon Alfa-2a and Ribavirin Achieved Significantly Higher SVR Rates In Treatment-Failure Patients with Chronic HCV Genotype 1 Compared to Control
Biopharmaceuticals

HSMN NewsFeed - 21 Mar 2011
Genentech Announces Positive Pivotal Phase II Results for Hedgehog Pathway Inhibitor in Advanced Basal Cell Carcinoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Mar 2011
Incyte’s Ruxolitinib (INCB18424) Meets Primary Endpoint in Second Phase III Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Mar 2011
Given Imaging Receives FDA Clearance for Expanded PillCam(R) SB Indications
Devices Gastroenterology FDA

HSMN NewsFeed - 1 Mar 2011
Forest Announces FDA Approval of Daliresp(TM) (Roflumilast) as a Treatment to Reduce the Risk of COPD Exacerbations in Patients with Severe COPD Associated with Chronic Bronchitis and a History of Exacerbations
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Feb 2011
Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Feb 2011
Orexigen(R) Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Feb 2011
Pervasis Receives FDA Fast Track Status for Vascugel(R) to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis
Biopharmaceuticals Interventional FDA

HSMN NewsFeed - 1 Feb 2011
FDA Issues Complete Response to New Drug Application for Contrave(R) for the Management of Obesity
Biopharmaceuticals FDA

HSMN NewsFeed - 31 Jan 2011
GATTEX(R) (teduglutide) Meets Primary Efficacy Endpoint in Phase 3 Pivotal Study in Patients with Adult Short Bowel Syndrome
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 21 Jan 2011
VIVUS Provides Regulatory Update on QNEXA NDA
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Dec 2010
VIVUS Files European Marketing Authorization Application for QNEXA(R) in the Treatment of Obesity
Biopharmaceuticals

HSMN NewsFeed - 10 Dec 2010
Pertuzumab and Herceptin Plus Chemotherapy Significantly Improved the Rate of Complete Tumor Disappearance in Study of Women With Newly Diagnosed, Early-Stage HER2-Positive Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Dec 2010
BioVex Commences OncoVEXGM-CSF Phase 3 Trial in Head and Neck Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Dec 2010
Florida Surgeon Completes World’S First Gastric Band with Spider(R) System
Devices Surgery

HSMN NewsFeed - 11 Nov 2010
FDA Approves EGRIFTA(TM) (Tesamorelin for Injection): The First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-Infected Patients With Lipodystrophy
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Nov 2010
Satiety’s TOGA(R) System Named a Top Medical Innovation by Cleveland Clinic Experts
Devices Gastroenterology

HSMN NewsFeed - 8 Nov 2010
New Magnetic Resonance Imaging (MRI) Data Show Efficacy of SIMPONI(R) in Treatment of Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 15 Oct 2010
GI Dynamics Receives European CE Mark Approval for 12 Months of EndoBarrier(TM) Treatment of Type 2 Diabetes and Obesity; Announces U.K. Launch
Devices Gastroenterology Endocrinology Regulatory

HSMN NewsFeed - 27 Sep 2010
Centocor Ortho Biotech Inc. Submits Application to FDA Seeking to Expand SIMPONI(R) Label in Treatment of Rheumatoid Arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Sep 2010
Novartis Drug SOM230 is First Medical Therapy to Show Efficacy in a Phase III Trial in Cushing's Disease, a Debilitating Hormonal Disorder
Biopharmaceuticals

HSMN NewsFeed - 9 Sep 2010
The Benefits of Crospon's EndoFLIP(R) System Presented at International Obesity Surgery Congress 2010
Devices

HSMN NewsFeed - 7 Sep 2010
GI Dynamics Announces New Data Showing Significant Weight Loss, Cardiovascular and Metabolic Improvements Following 12 Months of EndoBarrier Treatment
Devices Gastroenterology

HSMN NewsFeed - 1 Sep 2010
GI Dynamics Announces Distribution Agreement with Elemental Healthcare for the EndoBarrier Gastrointestinal Liner
Devices Distribution

HSMN NewsFeed - 23 Aug 2010
First European Incisionless Procedure to 'Reverse Weight Gain After Gastric Bypass Surgery' Takes Place in UK
Devices

HSMN NewsFeed - 19 Aug 2010
GI Dynamics Announces Key Executive Appointments in Preparation for European Launch of EndoBarrier Gastrointestinal Liner
Devices Gastroenterology Personnel

HSMN NewsFeed - 2 Aug 2010
EnteroMedics Achieves Major Milestones in Global Regulatory and Commercialization Strategy for the Maestro System
Devices Gastroenterology FDA

HSMN NewsFeed - 24 Jul 2010
Eisai Inc. and Pfizer Inc Announce U.S. FDA Approval for New Higher-Dose Aricept(R) (donepezil HCl) 23 mg Tablet for the Treatment of Moderate-to-Severe Alzheimer's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 1 Jul 2010
Eisai to Market Arena Pharmaceuticals' Lorcaserin for Obesity and Weight Management in U.S. Following FDA Approval
Biopharmaceuticals

HSMN NewsFeed - 1 Jul 2010
Eisai Inc. Enters Marketing and Supply Agreement with Arena Pharmaceuticals for Lorcaserin
Biopharmaceuticals

HSMN NewsFeed - 1 Jul 2010
Phase III Study Shows Novartis Drug Afinitor(R) More Than Doubles Time Without Tumor Growth in Advanced Pancreatic NET Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Jun 2010
Eisai Announces Results of Phase III Study of Dacogen(R) (Decitabine) for Injection in Acute Myeloid Leukemia (AML)
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Jun 2010
New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes
Biopharmaceuticals

HSMN NewsFeed - 14 Jun 2010
Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Jun 2010
Orexigen(R) Therapeutics Announces FDA Acceptance of Contrave(R) New Drug Application for the Treatment of Obesity
Biopharmaceuticals FDA

HSMN NewsFeed - 26 May 2010
Alvine Pharmaceuticals Announces Equity Investment by Abbott Biotech Ventures Inc.
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 5 May 2010
New Studies Presented at Digestive Disease Week Highlight the Value of PillCam(R) Capsule Endoscopy
Devices Gastroenterology

HSMN NewsFeed - 3 May 2010
Abbott Receives FDA Approval for CREON(R) to Include Dosing Information for Patients With Chronic Pancreatitis and Pancreatectomy
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Apr 2010
REMICADE(R) Study Results Show Greater Steroid-Free Remission and Mucosal Healing Compared With Conventional Immunomodulator Azathioprine in Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 30 Mar 2010
Heartland Spine & Specialty Hospital Undergoes Name Change
Hospitals & Healthcare Systems Surgery Orthopaedic

HSMN NewsFeed - 15 Mar 2010
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for Exenatide Once Weekly Submission
Biopharmaceuticals

HSMN NewsFeed - 2 Mar 2010
Orexigen(R) Therapeutics Appoints Peter Honig, M.D. to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Feb 2010
Arena Pharmaceuticals Receives PDUFA Date for Lorcaserin NDA
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Feb 2010
Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
Biopharmaceuticals

HSMN NewsFeed - 22 Feb 2010
EnteroMedics Appoints Dr. Scott Shikora as Consulting Chief Medical Officer
Devices Personnel

HSMN NewsFeed - 26 Jan 2010
Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 18 Jan 2010
Covidien and Allergan Extend Agreement to Promote LAP-BAND(R) Adjustable Gastric Banding System
Devices Surgery Distribution

HSMN NewsFeed - 7 Jan 2010
GI Dynamics Receives Strategic Investment from Medtronic, Inc.
Devices Gastroenterology Venture Capital

HSMN NewsFeed - 29 Dec 2009
VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Dec 2009
GI Dynamics Receives European CE Mark Approval for the EndoBarrier Gastrointestinal Liner System for the Treatment of Type 2 Diabetes and Obesity
Devices Gastroenterology Regulatory

HSMN NewsFeed - 23 Nov 2009
Four Senior Executives Join Orexigen(R) Therapeutics Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Nov 2009
Duke University Initiates Study of AEOL 10150 to Measure Compound's Ability to Protect Healthy Tissue in Mice Receiving Chemotherapy and Radiation for Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Oct 2009
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 Oct 2009
New SIMPONI(TM) Data Show Long-Term Efficacy in Treatment of Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 19 Oct 2009
New SIMPONI(TM) Data Show Inhibition of Joint Damage in Patients With Rheumatoid Arthritis and Psoriatic Arthritis
Biopharmaceuticals

HSMN NewsFeed - 5 Oct 2009
FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 30 Sep 2009
Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Sep 2009
Alvine Pharmaceuticals Raises $21.5 Million Series A Extension
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Sep 2009
Albert Einstein Healthcare Network Performs Region's First Single-Incision Laparoscopic Gastric Banding Surgery
Devices Surgery Gastroenterology

HSMN NewsFeed - 22 Jul 2009
Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Jul 2009
Cutting Edge Obesity Surgery Successfully Completed With Power Medical Interventions'(r) Intelligent Surgical Instruments(tm)
Devices Surgery

HSMN NewsFeed - 19 Jun 2009
Covidien Features New Devices for Minimally Invasive Surgery and Soft Tissue Repair at ASMBS 2009
Devices Surgery

HSMN NewsFeed - 1 Jun 2009
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Jun 2009
Results and Additional Analyses From Study Show That Corthera's Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables
Biopharmaceuticals Cardiology

HSMN NewsFeed - 20 May 2009
Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 7 May 2009
Results From Phase 3 EQUATE Trial of VIVUS' Qnexa Highlighted at European Congress on Obesity
Biopharmaceuticals

HSMN NewsFeed - 4 May 2009
Santa Barbara Medical Innovations(TM) Signs Deal in Excess of $500 Million With Erchonia Medical(TM) for ZERONA(TM) Laser Rights
Devices Distribution

HSMN NewsFeed - 29 Apr 2009
Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 24 Apr 2009
SIMPONI(TM) (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Apr 2009
Encouraging Results Published on Use of TomoTherapy in Lung Cancer Treatment
Devices Oncology

HSMN NewsFeed - 26 Mar 2009
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 20 Mar 2009
Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced
Biopharmaceuticals Product Recall

HSMN NewsFeed - 19 Mar 2009
Alvine Pharmaceuticals Appoints Dr. Daniel C. Adelman, M.D. as Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Mar 2009
FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Mar 2009
FDA Grants Orphan Drug Designation for EUR-1073
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 2 Mar 2009
ImClone Systems and Bristol-Myers Squibb Update Status of First-Line Squamous Cell Carcinoma of the Head and Neck Supplemental Biologics Application for ERBITUX(R) in U.S.
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 20 Feb 2009
Surgeons Perform First Incisionless Bariatric Procedure in the United States
Devices Surgery

HSMN NewsFeed - 19 Feb 2009
GI Dynamics Closes an Additional $15 Million in Series C Financing
Devices Venture Capital

HSMN NewsFeed - 27 Jan 2009
Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
Biopharmaceuticals

HSMN NewsFeed - 23 Jan 2009
ImClone Systems and Bristol-Myers Squibb Update the Status of Non-Small Cell Lung Cancer Supplemental Biologics Application Submission for ERBITUX(R)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 8 Jan 2009
Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints
Biopharmaceuticals

HSMN NewsFeed - 15 Dec 2008
COSMO ANNOUNCES STRATEGIC COLLABORATION WITH SANTARUS FOR U.S. RIGHTS TO BUDESONIDE MMX® AND RIFAMYCIN SV MMX®
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 8 Dec 2008
ERBITUX® Supplemental Biologics License Application for Advanced Non-Small Cell Lung Cancer Submitted to U.S. Food and Drug Administration
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Dec 2008
Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Nov 2008
Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Oct 2008
ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Oct 2008
BAROnova Secures Investment From Allergan, Inc.
Devices Venture Capital

HSMN NewsFeed - 21 Oct 2008
Abbott's HUMIRA(R) (adalimumab) Data Shows Fistula Healing for Up to Three Years in Patients with Moderate to Severe Crohn's Disease
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 20 Oct 2008
PillCam(R) COLON Shows Substantial Agreement With Gold Standard Colonoscopy in Detection of Ulcerative Colitis
Devices Gastroenterology

HSMN NewsFeed - 8 Oct 2008
One Year of GATTEX(TM) Therapy Safely Reduces Parenteral Nutrition Dependence for Patients with Short Bowel Syndrome
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 6 Oct 2008
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 30 Sep 2008
Cook Medical Continues to Drive Endoscopy Innovations with Industry's Strongest 3 Stage Balloon Dilator
Devices Gastroenterology

HSMN NewsFeed - 26 Sep 2008
GI Dynamics Announces Promising Multi-Center Safety and Efficacy Data of EndoBarrier(TM) Gastrointestinal Liner for Pre-Surgical Weight Loss
Devices

HSMN NewsFeed - 25 Sep 2008
Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Sep 2008
ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Sep 2008
ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Sep 2008
ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Sep 2008
Novare Announces Successful Series of Single Port Lap Band Procedures With RealHand(R) High Dexterity Instruments
Devices Surgery

HSMN NewsFeed - 29 Aug 2008
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Aug 2008
Noven Provides Update on Daytrana(R) Methylphenidate Transdermal System
Biopharmaceuticals Product Recall

HSMN NewsFeed - 28 Jul 2008
Nexavar Approved for Liver Cancer in China
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 25 Jul 2008
Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP
Biopharmaceuticals Cardiology

HSMN NewsFeed - 24 Jul 2008
FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
Biopharmaceuticals FDA Neurology

HSMN NewsFeed - 16 Jul 2008
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 14 Jul 2008
ImClone Announces Changes in Commercial Organization Leadership
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jul 2008
FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
Biopharmaceuticals Radiology FDA

HSMN NewsFeed - 7 Jul 2008
Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Jul 2008
FDA Grants Conditional Approval to Interventional Spine's PercuDyn(TM) System IDE Application
Devices Neurosurgery Orthopaedic FDA

HSMN NewsFeed - 23 Jun 2008
Studies Show USGI Medical's EndoSurgical Operating System(TM) Enables Incisionless Surgery to Reduce Gastric Pouch and Stoma After Gastric Bypass
Devices Surgery

HSMN NewsFeed - 12 Jun 2008
ORENCIA(R) (abatacept) Provided an Increasing Degree of Inhibition of Structural Damage Through Three Years in Adults with Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 10 Jun 2008
Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 9 Jun 2008
Noven Provides Update on Daytrana(TM) Methylphenidate Transdermal System
Biopharmaceuticals Product Recall

HSMN NewsFeed - 2 Jun 2008
ImClone Appoints Dr. Bernhard Ehmer Senior Vice President and Managing Director, International Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jun 2008
New Analyses of Pivotal Phase 3 Study of ERBITUX(R) Demonstrate Enhanced Efficacy in First-Line Metastatic Colorectal Cancer Patients with Wild-Type K-Ras Biomarker
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 May 2008
ERBITUX(R) (Cetuximab) Data Demonstrate Improved Overall Survival in First-Line Treatment of Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 21 May 2008
Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 19 May 2008
Phase 3 GATTEX(TM) Results Presented at Annual Digestive Disease Week Congress Highlight Potential New Treatment in Short Bowel Syndrome
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 16 May 2008
Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 May 2008
Orexigen(R) Therapeutics Announces Completion of Patient Enrollment in Phase III Clinical Program for Contrave(R)
Biopharmaceuticals

HSMN NewsFeed - 24 Apr 2008
Two Merck Medicines Recommended for Approval in the European Union
Biopharmaceuticals Regulatory

HSMN NewsFeed - 31 Mar 2008
Phase III Data Showed Taranabant, Merck's Investigational Medicine to Treat Obesity, Led to Statistically Significant Weight Loss
Biopharmaceuticals

HSMN NewsFeed - 28 Mar 2008
New York-Presbyterian/Weill Cornell is First New York Medical Center to Offer Tantalus Clinical Trial to Diabetes Patients
Devices Endocrinology

HSMN NewsFeed - 17 Mar 2008
NPS Reports Successful GATTEX(TM) Extension Study
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 3 Mar 2008
AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
Biopharmaceutical Acquisitions

HSMN NewsFeed - 18 Feb 2008
Bayer and Onyx Provide Update on Phase 3 Trial of Nexavar in Patients With Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 Jan 2008
FDA Approves TYSABRI(R) for the Treatment of Moderate-to-Severe Crohn's Disease
Biopharmaceuticals FDA Gastroenterology

HSMN NewsFeed - 7 Jan 2008
EnteroMedics(TM) Announces Pivotal Clinical Study of its VBLOC(TM) Therapy for Obesity
Devices

HSMN NewsFeed - 7 Jan 2008
Cohera Medical, Inc. Expands Management Team
Devices Wound Care Personnel

HSMN NewsFeed - 7 Jan 2008
SYMLIN Pen-Injector Devices Now Available
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 19 Dec 2007
Biogen Idec Announces First Startup in Its Innovation Incubator
Biopharmaceuticals

HSMN NewsFeed - 12 Dec 2007
VIVUS Initiates Third Qnexa Phase 3 Trial in Obese Patients
Biopharmaceuticals

HSMN NewsFeed - 11 Dec 2007
OREXIGEN(TM) Therapeutics Initiates Fourth Phase III Trial for Contrave(TM) to Treat Obesity
Biopharmaceuticals

HSMN NewsFeed - 6 Dec 2007
Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 28 Nov 2007
MetaCure(TM) Launches Investigational Study of Gastric Stimulator for Patients With Type 2 Diabetes Who are Overweight
Devices

HSMN NewsFeed - 26 Nov 2007
GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
Biopharmaceuticals

HSMN NewsFeed - 19 Nov 2007
Nexavar First FDA-Approved Drug Therapy for Liver Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 16 Nov 2007
VIVUS Initiates Second Qnexa Pivotal Phase 3 Trial in Obese Patients
Biopharmaceuticals

HSMN NewsFeed - 12 Nov 2007
Allergan, Inc. and Covidien Ltd. Enter into Co-Promotion Agreement for LAP-BAND(R) Adjustable Gastric Banding System
Devices

HSMN NewsFeed - 9 Nov 2007
Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
Biopharmaceuticals

HSMN NewsFeed - 8 Nov 2007
Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab)
Biopharmaceuticals

HSMN NewsFeed - 29 Oct 2007
Gilead Announces 48-Week Data Evaluating Switching from Combivir(R) To Truvada(R) Among Virologically-Suppressed HIV Patients
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 24 Oct 2007
Liver Health Improves after Bariatric Surgery
Surgery

HSMN NewsFeed - 17 Oct 2007
FDA Approves Supplemental New Drug Applications for JANUVIA(TM) (sitagliptin)
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 17 Oct 2007
OREXIGEN(TM) Therapeutics Initiates its Third Phase III Trial for Contrave(TM) to Treat Obesity
Biopharmaceuticals

HSMN NewsFeed - 15 Oct 2007
Clinical Studies Show REMICADE Reduces Incidence of Bowel Surgeries in Ulcerative Colitis Patients
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 15 Oct 2007
Elan and Biogen Idec Announce That FDA Will Extend Regulatory Review Period for TYSABRI(R) for Crohn's Disease
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 1 Oct 2007
FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use
Devices Drug Delivery Endocrinology FDA

HSMN NewsFeed - 28 Sep 2007
FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
Devices Surgery FDA

HSMN NewsFeed - 21 Sep 2007
One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 20 Sep 2007
FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 19 Sep 2007
Orexigen(TM) Announces Settlement Agreement with Eisai
Biopharmaceuticals Litigation

HSMN NewsFeed - 11 Sep 2007
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Sep 2007
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
Biopharmaceuticals Oncology Litigation Licensing

HSMN NewsFeed - 6 Sep 2007
Plastic and Reconstructive Surgery Publishes Clinical Trial Results of Ultrashape(TM) Non-Invasive Body Contouring System
Devices

HSMN NewsFeed - 4 Sep 2007
Noven Provides Update on Daytrana(TM) Methylphenidate Transdermal System
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 4 Sep 2007
Shire Voluntarily Withdraws a Limited Portion of DAYTRANA(TM) (Methylphenidate Transdermal System) Patches
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 27 Aug 2007
Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
Biopharmaceuticals

HSMN NewsFeed - 22 Aug 2007
Bariatric Surgical Society Takes on New Name, New Mission and New Surgery
Surgery Endocrinology

HSMN NewsFeed - 7 Aug 2007
ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Jul 2007
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
Biopharmaceuticals Oncology

HSMN NewsFeed - 24 Jul 2007
OREXIGEN(TM) Therapeutics Reports Top-line 24 Week Results for Phase IIb Trial of EMPATIC(TM) to Treat Obesity
Biopharmaceuticals

HSMN NewsFeed - 19 Jul 2007
Elan and Biogen Idec Preparing to Appeal Ruling on European Application for Natalizumab for the Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 17 Jul 2007
Satiety, Inc. Completes $30 Million Series D Financing
Devices Gastroenterology Venture Capital

HSMN NewsFeed - 12 Jul 2007
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Jul 2007
Manhattan Pharmaceuticals Provides Update on Clinical Pipeline
Biopharmaceuticals

HSMN NewsFeed - 29 Jun 2007
Rimonabant Regulatory Update in the United States
Biopharmaceuticals

HSMN NewsFeed - 24 Jun 2007
BYETTA(R) Study Showed Comparable Blood Glucose Control to Insulin
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 23 Jun 2007
SYMLIN(R) Used in Conjunction with Basal Insulin in Patients with Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 23 Jun 2007
BYETTA(R) Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 21 Jun 2007
VIVUS Completes End of Phase 2 Meeting with the FDA for Qnexa, a Treatment for Obesity
Biopharmaceuticals

HSMN NewsFeed - 18 Jun 2007
Oragenics Appoints Dr. Ronald P. Evens to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jun 2007
Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia(R) (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
Biopharmaceuticals

HSMN NewsFeed - 11 Jun 2007
FDA Accepts and Grants Priority Review of ERBITUX(R) (Cetuximab) sBLA for Overall Survival in Patients with Advanced Colorectal Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 8 Jun 2007
International Movement Disorder Specialists Receive New Information About the Use of Once-Daily AZILECT(R) in the Treatment of Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 7 Jun 2007
Abbott's HUMIRA(R) (Adalimumab) Approved in the European Union for the Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 7 Jun 2007
Remicade(R) Receives EU Approval as First and Only Biologic Treatment for Pediatric Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 5 Jun 2007
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Jun 2007
Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 May 2007
Elan and Biogen Idec Announce a FDA Advisory Committee Meeting to Review TYSABRI(R) for the Treatment of Crohn's Disease
Biopharmacetuicals Gastroenterology FDA

HSMN NewsFeed - 22 May 2007
Enzo Biochem Individualized Oral Immune Regulation Therapy May Be Effective Approach to Treating Crohn's Disease
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 22 May 2007
Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term Safety Study of LIALDA(TM) (mesalamine) Presented at DDW
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 19 May 2007
FDA Issues Approvable Letter for SPD465 (Triple-Bead Mixed Amphetamine Salts) for the Treatment of ADHD in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 17 May 2007
Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 2 May 2007
Amarillo Biosciences Issues Corporate Update on Influenza and Hepatitis C Research and Behcet's Disease and Oral Warts Phase 2 Trials
Biopharmaceuticals

HSMN NewsFeed - 27 Apr 2007
Abbott's HUMIRA(R) (Adalimumab) Receives Positive Opinion from European Medicines Agency for the Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 25 Apr 2007
OSI Pharmaceuticals Announces Pivotal Phase III Tarceva(R) Study Published in the Journal of Clinical Oncology Showed Survival Improvement in Patients with Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Apr 2007
Randomized Phase III Trial Showed ERBITUX Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Apr 2007
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Apr 2007
Survival Data Available From ERBITUX(R) Study in First-Line Treatment of Advanced Head and Neck Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Apr 2007
FDA Approves JANUMET(TM) for Type 2 Diabetes, Offering Powerful Glucose Control of a DPP-4 Inhibitor and Metformin in a Single Tablet
Biopharmaceuticals FDA Endocrinology

HSMN NewsFeed - 26 Mar 2007
European Union CHMP Recommends Approval of First and Only Biologic Treatment for Pediatric Crohn's Disease: REMICADE(R)
Biopharmaceuticals Regulatory Gastroenterology

HSMN NewsFeed - 19 Mar 2007
LIALDA(TM) (mesalamine) With MMX(TM) Technology - the First Oral Once-Daily Mesalamine for Active, Mild to Moderate Ulcerative Colitis - Now Available
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 27 Feb 2007
American Heart Association Scientific Statement: AHA Statement Recommends Doctors Change Approach to Prescribing Pain Relievers for Patients With or at Risk for Heart Disease
Biopharmaceuticals Cardiology

HSMN NewsFeed - 27 Feb 2007
HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 26 Feb 2007
Long-Term Safety Data Show the LAP-BAND(R) Adjustable Gastric Banding System Results in Fewer Complications Compared to Gastric Bypass
Devices Gastroenterology

HSMN NewsFeed - 22 Feb 2007
Allergan Announces Its Acquisition of EndoArt, a Leading Swiss Developer of Remote-Controlled Medical Devices
Devices Mergers & Acquisitions

HSMN NewsFeed - 20 Feb 2007
New Storage Instructions Approved for BYETTA(R)
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 6 Feb 2007
Study Showing Benefits of Ultrafiltration Therapy for Heart Failure Patients Published in Journal of American College of Cardiology
Devices Cardiology

HSMN NewsFeed - 5 Feb 2007
Abdominal Surgical Procedures Without Skin Incisions
Devices Surgery FDA

HSMN NewsFeed - 5 Feb 2007
ImClone Systems Incorporated and Bristol-Myers Squibb Announce Application In Japan for Use of ERBITUX in Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 29 Jan 2007
OSI Pharmaceuticals Announces European Regulatory Approval of Tarceva(R) for Treatment of Patients with Pancreatic Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 17 Jan 2007
Elixir Pharmaceuticals Presents New Data Highlighting Ghrelin Inhibition as a Potential Method for Regulating Metabolism and Treating Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 16 Jan 2007
FDA Approves LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine for Patients With Active, Mild to Moderate Ulcerative Colitis
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 16 Jan 2007
Vicus Therapeutics Announces the FDA has Allowed the Phase 2 Trial of VT-122 for the Treatment of Cachexia in Patients With Advanced Lung Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 10 Jan 2007
ERBITUX(R) Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Jan 2007
EndoGastric Solutions, Inc. Completes Five Fully Transoral Redo-Obesity Procedures: Without Skin Incision - In As Little As 20 Minutes
Devices

HSMN NewsFeed - 5 Jan 2007
Savient Pharmaceuticals Restructures Commercial Operations Following Launch of Authorized Generic
Biopharmaceuticals Generics

HSMN NewsFeed - 3 Jan 2007
Genaera Corporation Terminates EVIZON(TM) Clinical Program and Restructures
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 3 Jan 2007
FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 29 Dec 2006
Savient Pharmaceuticals Announces Launch of Authorized Generic of Oxandrin(R) with Watson Pharmaceuticals
Biopharmaceuticals Generics

HSMN NewsFeed - 22 Dec 2006
FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 22 Dec 2006
Largest Disease Modification Trial for Parkinson's Disease Completes Enrollment
Biopharmaceuticals Neurology

HSMN NewsFeed - 15 Dec 2006
Elan and Biogen Idec Submit Supplemental Biologics License Application to the FDA for the Approval of TYSABRI(R) as a Treatment for Crohn's Disease
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 15 Dec 2006
OSI Pharmaceuticals Announces That Tarceva(R) Received Positive Opinion from Health Authorities in European Union for the Treatment of Patients with Pancreatic Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 13 Dec 2006
Kemia Announces Appointment of Senior VP of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Dec 2006
Savient Pharmaceuticals Announces Appellate Court Decision in Patent Infringement Lawsuit against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 12 Dec 2006
Merck Remains Confident in Future Growth as it Executes on New Strategy
Biopharmaceuticals

HSMN NewsFeed - 5 Dec 2006
Savient Pharmaceuticals Obtains Temporary Restraining Order in Patent Infringement Lawsuit Against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 5 Dec 2006
New Data Shows Rimonabant Benefited Patients with Type 2 Diabetes by Improving Blood Sugar Control, Reducing Weight and Acting on Other Cardiometabolic Risk Factors
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 4 Dec 2006
Savient Pharmaceuticals Files Patent Infringement Lawsuit Against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 22 Nov 2006
OREXIGEN(TM) Therapeutics Completes $30 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Nov 2006
Shire Announces Results of its Bioequivalence Study of SPD465, an Investigational Drug for Adults with ADHD
Biopharmaceuticals

HSMN NewsFeed - 16 Nov 2006
Shire Announces Results of a Meta-Analysis Comparing Stimulant Medications to Non-Stimulant Medications in Treating ADHD in Patients Aged 8 to 15
Biopharmaceuticals

HSMN NewsFeed - 14 Nov 2006
ORENCIA(R) (abatacept) or REMICADE(R)(infliximab) Demonstrated Superior Efficacy to Placebo at Six Months With ORENCIA Demonstrating Both Durable Efficacy and a More Favorable Safety Profile Through 12 Months
Biopharmaceuticals

HSMN NewsFeed - 13 Nov 2006
ORENCIA(R) (abatacept) Data Demonstrated Improvement in Children and Adolescents With Juvenile Idiopathic Arthritis as Measured by the Validated ACR Pediatric Criteria
Biopharmaceuticals

HSMN NewsFeed - 9 Nov 2006
Two-Year Data for ORENCIA(R) (abatacept) Demonstrate Continued Efficacy in Adults With Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 6 Nov 2006
Survival Data Available from Two Randomized ERBITUX Studies in Metastatic Colorectal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Oct 2006
DAYTRANA(TM) (methylphenidate transdermal system) Provides Individualized Symptom Management
Biopharmaceuticals

HSMN NewsFeed - 26 Oct 2006
Abbott's HUMIRA(R) (Adalimumab) Granted FDA Priority Review for the Treatment of Moderately to Severely Active Crohn's Disease
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 24 Oct 2006
Amylin Pharmaceuticals Expands Clinical Program in Obesity
Biopharmaceuticals

HSMN NewsFeed - 24 Oct 2006
Further Analysis of Phase III Data Using CALGB and EORTC Paradigms Reinforces Survival Benefits of ONCONASE(R) for the Treatment of Patients with Mesothelioma
Biopharmaceuticals Oncology

HSMN NewsFeed - 24 Oct 2006
TYSABRI(R) Maintained Remission in Patients with Moderate-to-Severe Crohn's Disease Treated for Longer Than Two Years According to Data Presented This Week
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 23 Oct 2006
Salix Pharmaceuticals Reports American College of Gastroenterology Update
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 23 Oct 2006
New Phase III Data Shows Abbott's HUMIRA(R) (Adalimumab) Induced Clinical Remission In Patients With Crohn's Disease Who Lost Response to, or Were Intolerant to, Remicade(R) (Infliximab)
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 22 Oct 2006
Study Results Found Low-Dose Orlistat (60 mg) Demonstrates Significant Reduction in LDL Cholesterol While Providing Weight Loss for Up to Two Years
Biopharmaceuticals

HSMN NewsFeed - 22 Oct 2006
OREXIGEN(TM) Therapeutics Reports Positive Phase II Results for Excalia(TM) Combination-Therapy to Treat Obesity
Biopharmaceuticals

HSMN NewsFeed - 19 Oct 2006
FDA Expands REMICADE(R) Indication for Ulcerative Colitis: Biologic Maintains Long-Term Clinical Remission and Mucosal Healing
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 12 Oct 2006
Endo Pharmaceuticals Acquires RxKinetix, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 4 Oct 2006
OREXIGEN(TM) Therapeutics Expands Senior Management Team as Lead Products Advance Through Late-Stage Clinical Trials
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Sep 2006
Savient Pharmaceuticals Files Patent Infringement Lawsuit Against Barr Laboratories Inc.
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 19 Sep 2006
PhytoMedical Announces Appointment of Senior Pharmaceutical Executives to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Sep 2006
Type 2 Diabetes Patients on Technosphere Insulin Exhibited No Adverse Effect on Pulmonary Function with Significant HbA1c Reductions, and Showed Significant Weight Reduction Compared to Injected Insulin Analog
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 14 Sep 2006
Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Biphasic Insulin Aspart
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 12 Sep 2006
Arena Pharmaceuticals Initiates Lorcaserin Phase 3 Obesity Clinical Trial
Biopharmaceuticals

HSMN NewsFeed - 7 Sep 2006
Abbott Submits U.S. and E.U. Regulatory Applications Seeking Approval for HUMIRA(R) (Adalimumab) as a Treatment for Crohn's Disease
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 7 Sep 2006
SYMLIN Improved Diabetes Control in Patients With Type 2 Diabetes on Established Regimens of Basal Insulin
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 7 Sep 2006
Xenical(R) Shown to Improve Control of Blood Glucose Levels in People With Type 2 Diabetes Beyond Impact of Weight Loss Alone
Biopharmaceuticals

HSMN NewsFeed - 19 Jul 2006
Exelon(R) Patch, the first transdermal therapy for Alzheimer's disease, may provide a promising new approach to treatment
Biopharmaceuticals Neurology

HSMN NewsFeed - 12 Jul 2006
Teva Will Be Sole Promoter of AZILECT(R) for Parkinson's Disease in the United States
Biopharmaceuticals Neurology

HSMN NewsFeed - 11 Jul 2006
Procter & Gamble Pharmaceuticals and ARYx Therapeutics Form Alliance for an Investigational Treatment for Gastrointestinal Disorders
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 29 Jun 2006
Noven Confirms Availability of Daytrana(TM) Methylphenidate Transdermal System
Biopharmaceuticals

HSMN NewsFeed - 29 Jun 2006
Shire's DAYTRANA(TM), First Transdermal Medication for Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children, Now Available in Pharmacies
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 27 Jun 2006
The U.S. Food and Drug Administration Approves Exelon(R) (rivastigmine tartrate) as the First Medication Indicated to Treat Parkinson's Disease Dementia
Biopharmaceuticals FDA Neurology

HSMN NewsFeed - 25 May 2006
Significant ADHD Symptom Control With Shorter DAYTRANA(TM) (methylphenidate transdermal system) Wear Time
Biopharmaceuticals

HSMN NewsFeed - 24 May 2006
Positive Study Results for DAYTRANA(TM) (methylphenidate transdermal system) Presented at a Major Medical Meeting
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 24 May 2006
OREXIGEN(TM) Therapeutics Appoints Graham Cooper as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 May 2006
New Studies Examine SEROQUEL(R) in Combination With Antidepressant Therapy in Patients With Depression
Biopharmaceuticals

HSMN NewsFeed - 22 May 2006
Promising Pivotal Phase III Data Show Abbott's Humira(R) (Adalimumab) Maintained Clinical Remission in Patients With Crohn's Disease Through One Year
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 17 May 2006
FDA Advisory Committee Recommends Approval of Exelon(R) (rivastigmine tartrate) in the Treatment of Dementia Associated with Parkinson's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 17 May 2006
AZILECT(R) FDA Approval Brings New Hope to People Living With Parkinson's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 17 May 2006
Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 16 May 2006
Manhattan Pharmaceuticals Receives SwissMedic's Approval to Commence Phase IIa Trial With OE, Its Oral Obesity Drug Candidate
Biopharmaceuticals

HSMN NewsFeed - 10 May 2006
VIVUS Announces Positive Phase 2 Clinical Trial Results With Qnexa, a Novel Therapy to Treat Obesity
Biopharmaceuticals

Return to NewsFeed

Additional items found! 201

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 201 additional stories matching:
weight loss
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!